A psychology lecturer from the University of Central Lancashire (UCLan) has been recognised as an ‘exceptional’ biomedical and health researcher after receiving funding from the Academy of Medical Sciences.
Dr Philipp Ruhnau is one of 54 researchers to receive a share of more than £6.6 million through the Academy’s Springboard scheme, which support early career scientists to establish their independent research careers over the next two years.
Philipp’s £108,147 grant will allow him to develop his brain stimulation research, which looks at the way different areas of the brain communicate and how to influence this in order to provide treatments for mental health issues such as mood disorders, specifically depression.
"It gives me the chance to focus on my own research line on a topic that I have been keen on pursuing for some time."
— A psychology lecturer Dr Philipp Ruhnau
It is the first time UCLan has received Springboard funding. The programme assists researchers across the full breadth of biomedical science, from molecular biology through to public health. Projects funded this year will advance understanding across a diverse range of health areas including cancer, antimicrobial resistance, musculoskeletal conditions and mental health. Along with the grant, Springboard recipients benefit from the Academy’s mentoring opportunities and career development programmes.
The Springboard programme responds to the Academy’s call for greater security and career development opportunities for health researchers, as highlighted in its ‘Future Proofing UK Health Research’ report. By providing substantial funding and access to mentoring over two years, the programme aims to help emerging research leaders establish their independent research careers and contribute to a sustainable pipeline of research talent in the UK.
"The Academy, together with our partners, is committed to cultivating the next generation of biomedical research leaders and ensuring they have the resources and support necessary to realise their immense potential."
— Professor James Naismith FMedSci, Vice-President (Non-Clinical) at the Academy of Medical Sciences
Professor James Naismith FMedSci, Vice-President (Non-Clinical) at the Academy of Medical Sciences, said: “Scientists face immense challenges as they begin their careers, and the Academy recognises the hurdles early career researchers must navigate as they establish themselves, which is why initiatives like Springboard are vital. Through this unique programme, we are extremely pleased to support 54 exceptional scientists with our largest-ever round of funding.
"The Academy, together with our partners, is committed to cultivating the next generation of biomedical research leaders and ensuring they have the resources and support necessary to realise their immense potential. By providing substantial financial backing and access to invaluable career development opportunities at this critical stage, we can enable talented researchers to deliver breakthroughs and innovations to improve human health."
The Springboard programme is supported by the Department for Science, Innovation and Technology (DSIT), Wellcome, British Heart Foundation and Diabetes UK.